(NYSE: MD) MEDNAX's forecast annual revenue growth rate of 5.3% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.2%.
MEDNAX's revenue in 2022 is $1,946,667,000.On average, 6 Wall Street analysts forecast MD's revenue for 2022 to be $175,375,740,317, with the lowest MD revenue forecast at $173,676,497,770, and the highest MD revenue forecast at $178,179,189,467. On average, 6 Wall Street analysts forecast MD's revenue for 2023 to be $185,477,389,521, with the lowest MD revenue forecast at $177,976,742,864, and the highest MD revenue forecast at $189,414,975,958.
In 2024, MD is forecast to generate $201,678,702,530 in revenue, with the lowest revenue forecast at $201,678,702,530 and the highest revenue forecast at $201,678,702,530.